EUVIMEDEUVIMED entdecken
Open Access

Dopamine D1‐like receptor activation decreases nicotine intake in rats with short or long access to nicotine

Ranjithkumar Chellian, Azin Behnood-Rod, Ryann Wilson, Karen Lin, Grace Wing-Yan King, Adriaan W Bruijnzeel iD

Addiction Biology · 2023-08 · 28 (8)

DOI: 10.1111/adb.13312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction Biology, online erschienen am 13.07.2023. Verfasst von Ranjithkumar Chellian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Nicotine, Dopamine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of nicotine and tobacco products is highly addictive. The dopaminergic system plays a key role in the initiation and maintenance of nicotine intake. Dopamine D1‐like receptor blockade diminishes nicotine intake in rats with daily short (1 h) access to nicotine, but little is known about the effects of dopamine receptor antagonists or agonists on nicotine intake in rats with intermittent long (23 h) access. Because of the extended access conditions and high nicotine intake, the intermittent long access procedure might model smoking and vaping better than short access models. We investigated the effects of the dopamine D1‐like receptor antagonist SCH 23390 and the D1‐like receptor agonist A77636 on nicotine intake in male rats with intermittent short or long access to nicotine. The rats self‐administered nicotine for 5 days (1 h/day) and were then given 15 intermittent short (1 h/day) or long (23 h/day) access sessions (3 sessions/week, 0.06 mg/kg/inf). The D1‐like receptor antagonist SCH 23390 decreased nicotine intake to a similar degree in rats with short or long access to nicotine. The D1‐like receptor agonist A77636 induced a greater decrease in nicotine intake in the rats with long access to nicotine than in rats with short access. Treatment with A77636 induced a prolonged decrease in nicotine intake that lasted throughout the dark and light phase in the long access rats. These findings indicate that blockade and stimulation of D1‐like receptors decrease nicotine intake in an intermittent long access animal model that closely models human smoking and vaping.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NicotineDopamineHumansRatsMaleAnimalsReceptors, Dopamine D1BenzopyransBenzazepinesAdamantane

Stichwörter der Autor:innen

D1-like receptorsdopaminelong accessnicotineratsself-administrationshort access

Substanzen

NicotineDopamineReceptors, Dopamine D1BenzopyransBenzazepinesA 77636Adamantane

Autor:innen und Institutionen

  • Department of Psychiatry, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Adriaan W Bruijnzeel

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Chellian, R., Behnood-Rod, A., Wilson, R., Lin, K., King, G. W., & Bruijnzeel, A. W. (2023). Dopamine D1‐like receptor activation decreases nicotine intake in rats with short or long access to nicotine. Addiction Biology, 28(8). https://doi.org/10.1111/adb.13312

Vancouver

Chellian R, Behnood-Rod A, Wilson R, Lin K, King GW, Bruijnzeel AW. Dopamine D1‐like receptor activation decreases nicotine intake in rats with short or long access to nicotine. Addiction Biology. 2023;28(8). doi:10.1111/adb.13312

BibTeX
@article{Chellian2023,
  author = {Chellian, Ranjithkumar and Behnood-Rod, Azin and Wilson, Ryann and Lin, Karen and King, Grace Wing-Yan and Bruijnzeel, Adriaan W},
  title = {Dopamine D1‐like receptor activation decreases nicotine intake in rats with short or long access to nicotine},
  journal = {Addiction Biology},
  year = {2023},
  volume = {28},
  number = {8},
  doi = {10.1111/adb.13312}
}
Kostenlos starten →